The research from the FDA Adverse Event Reporting System revealed elevated reporting odds ratios for alopecia with semaglutide (2.46) and tirzepatide (1.73), though notably not with older GLP-1 medications like liraglutide or dulaglutide
Approaches: abdominal, laparoscopic, robotic assistance, hysteroscopic The method chosen depends on fibroid size, number, location, patient health, and fertility plans
Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV
Finally, the authors examined the therapeutic potential of their findings in cancer, given how metabolism in the microenvironment can impact on anti-tumor immunity
Serum cobalamin, homocysteine and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities
Am J Physiol Gastrointest Liver Physiol